Alizé Pharma
French tech company | Builders Republic
About
Biotech developing peptide drugs for rare endocrine and metabolic diseases — from the drug candidate (livoletide, an unacylated ghrelin analogue) to its clinical development in Prader-Willi syndrome and type 2 diabetes, in partnership with pharmaceutical companies.
Key facts
- Status
- Rachetée
- Sectors
- Healthcare & Life Sciences
- Latest stage
- Venture Round
- Founded
- 2007
- Region
- Auvergne-Rhône-Alpes
- Tracked rounds
- 3
- Amount raised
- 11 M€
Operations
- Venture Round · 2014
- Venture Round · 2012
- Venture Round · 2009